nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—ABCB1—kidney cancer	0.176	1	CbGaD
Fentanyl—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0569	0.1	CbGbCtD
Fentanyl—CYP3A7—Temsirolimus—kidney cancer	0.0569	0.1	CbGbCtD
Fentanyl—CYP3A5—Temsirolimus—kidney cancer	0.0427	0.0754	CbGbCtD
Fentanyl—ABCB1—Temsirolimus—kidney cancer	0.0278	0.049	CbGbCtD
Fentanyl—CYP3A4—Everolimus—kidney cancer	0.0246	0.0435	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.0195	0.0345	CbGbCtD
Fentanyl—CYP3A7—Paclitaxel—kidney cancer	0.0195	0.0345	CbGbCtD
Fentanyl—CYP3A7—Sorafenib—kidney cancer	0.0173	0.0306	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.0173	0.0306	CbGbCtD
Fentanyl—CYP3A7—Vincristine—kidney cancer	0.0168	0.0297	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.0168	0.0297	CbGbCtD
Fentanyl—CYP3A4—Temsirolimus—kidney cancer	0.0166	0.0294	CbGbCtD
Fentanyl—CYP3A5—Erlotinib—kidney cancer	0.016	0.0282	CbGbCtD
Fentanyl—CYP3A5—Paclitaxel—kidney cancer	0.0146	0.0259	CbGbCtD
Fentanyl—ABCB1—Pazopanib—kidney cancer	0.0146	0.0258	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.014	0.0248	CbGbCtD
Fentanyl—CYP3A7—Sunitinib—kidney cancer	0.014	0.0248	CbGbCtD
Fentanyl—ABCB1—Dactinomycin—kidney cancer	0.0133	0.0236	CbGbCtD
Fentanyl—CYP3A5—Sorafenib—kidney cancer	0.013	0.023	CbGbCtD
Fentanyl—CYP3A5—Vincristine—kidney cancer	0.0126	0.0223	CbGbCtD
Fentanyl—ABCB1—Gemcitabine—kidney cancer	0.0105	0.0186	CbGbCtD
Fentanyl—CYP3A5—Sunitinib—kidney cancer	0.0105	0.0186	CbGbCtD
Fentanyl—ABCB1—Erlotinib—kidney cancer	0.0104	0.0184	CbGbCtD
Fentanyl—ABCB1—Paclitaxel—kidney cancer	0.00953	0.0168	CbGbCtD
Fentanyl—CYP3A4—Pazopanib—kidney cancer	0.00874	0.0154	CbGbCtD
Fentanyl—ABCB1—Sorafenib—kidney cancer	0.00846	0.0149	CbGbCtD
Fentanyl—ABCB1—Vinblastine—kidney cancer	0.00836	0.0148	CbGbCtD
Fentanyl—ABCB1—Vincristine—kidney cancer	0.00822	0.0145	CbGbCtD
Fentanyl—ABCB1—Sunitinib—kidney cancer	0.00686	0.0121	CbGbCtD
Fentanyl—CYP3A4—Erlotinib—kidney cancer	0.00624	0.011	CbGbCtD
Fentanyl—CYP3A4—Paclitaxel—kidney cancer	0.00571	0.0101	CbGbCtD
Fentanyl—ABCB1—Doxorubicin—kidney cancer	0.00514	0.00907	CbGbCtD
Fentanyl—CYP3A4—Sorafenib—kidney cancer	0.00507	0.00896	CbGbCtD
Fentanyl—CYP3A4—Vinblastine—kidney cancer	0.00501	0.00884	CbGbCtD
Fentanyl—CYP3A4—Vincristine—kidney cancer	0.00492	0.00869	CbGbCtD
Fentanyl—CYP3A4—Sunitinib—kidney cancer	0.00411	0.00726	CbGbCtD
Fentanyl—CYP3A4—Doxorubicin—kidney cancer	0.00308	0.00543	CbGbCtD
Fentanyl—Loperamide—POMC—kidney cancer	0.00059	0.273	CrCbGaD
Fentanyl—Trimethaphan—BCHE—kidney cancer	0.000399	0.185	CrCbGaD
Fentanyl—Alfentanil—ABCB1—kidney cancer	0.000199	0.0924	CrCbGaD
Fentanyl—Phenylbutazone—PTGS1—kidney cancer	0.000196	0.0909	CrCbGaD
Fentanyl—Astemizole—ABCB1—kidney cancer	0.000155	0.0719	CrCbGaD
Fentanyl—Phenylbutazone—PTGS2—kidney cancer	0.000112	0.0519	CrCbGaD
Fentanyl—Fexofenadine—ABCB1—kidney cancer	0.00011	0.0512	CrCbGaD
Fentanyl—Diphenhydramine—PTGS1—kidney cancer	0.000107	0.0494	CrCbGaD
Fentanyl—Propafenone—ABCB1—kidney cancer	8.9e-05	0.0413	CrCbGaD
Fentanyl—Bepridil—ABCB1—kidney cancer	7.93e-05	0.0368	CrCbGaD
Fentanyl—Loperamide—ABCB1—kidney cancer	7.03e-05	0.0326	CrCbGaD
Fentanyl—Methadone—ABCB1—kidney cancer	5e-05	0.0232	CrCbGaD
Fentanyl—Shock—Paclitaxel—kidney cancer	4.02e-05	0.000159	CcSEcCtD
Fentanyl—Vomiting—Sorafenib—kidney cancer	4.02e-05	0.000159	CcSEcCtD
Fentanyl—Orthostatic hypotension—Doxorubicin—kidney cancer	4.02e-05	0.000159	CcSEcCtD
Fentanyl—Abdominal pain upper—Doxorubicin—kidney cancer	4.02e-05	0.000159	CcSEcCtD
Fentanyl—Nervous system disorder—Paclitaxel—kidney cancer	4.01e-05	0.000158	CcSEcCtD
Fentanyl—Hypokalaemia—Doxorubicin—kidney cancer	4.01e-05	0.000158	CcSEcCtD
Fentanyl—Thrombocytopenia—Paclitaxel—kidney cancer	4.01e-05	0.000158	CcSEcCtD
Fentanyl—Tachycardia—Paclitaxel—kidney cancer	3.99e-05	0.000158	CcSEcCtD
Fentanyl—Rash—Sorafenib—kidney cancer	3.99e-05	0.000158	CcSEcCtD
Fentanyl—Dermatitis—Sorafenib—kidney cancer	3.99e-05	0.000157	CcSEcCtD
Fentanyl—Back pain—Capecitabine—kidney cancer	3.98e-05	0.000157	CcSEcCtD
Fentanyl—Breast disorder—Doxorubicin—kidney cancer	3.98e-05	0.000157	CcSEcCtD
Fentanyl—Skin disorder—Paclitaxel—kidney cancer	3.97e-05	0.000157	CcSEcCtD
Fentanyl—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	3.96e-05	0.000157	CcSEcCtD
Fentanyl—Headache—Sorafenib—kidney cancer	3.96e-05	0.000157	CcSEcCtD
Fentanyl—Muscle spasms—Capecitabine—kidney cancer	3.95e-05	0.000156	CcSEcCtD
Fentanyl—Hyperhidrosis—Paclitaxel—kidney cancer	3.95e-05	0.000156	CcSEcCtD
Fentanyl—Diarrhoea—Dactinomycin—kidney cancer	3.94e-05	0.000156	CcSEcCtD
Fentanyl—Nasopharyngitis—Doxorubicin—kidney cancer	3.94e-05	0.000155	CcSEcCtD
Fentanyl—Anorexia—Paclitaxel—kidney cancer	3.9e-05	0.000154	CcSEcCtD
Fentanyl—Gastritis—Doxorubicin—kidney cancer	3.9e-05	0.000154	CcSEcCtD
Fentanyl—Muscular weakness—Doxorubicin—kidney cancer	3.88e-05	0.000153	CcSEcCtD
Fentanyl—Vision blurred—Capecitabine—kidney cancer	3.88e-05	0.000153	CcSEcCtD
Fentanyl—Vomiting—Sunitinib—kidney cancer	3.87e-05	0.000153	CcSEcCtD
Fentanyl—Body temperature increased—Gemcitabine—kidney cancer	3.86e-05	0.000153	CcSEcCtD
Fentanyl—Tremor—Capecitabine—kidney cancer	3.85e-05	0.000152	CcSEcCtD
Fentanyl—Rash—Sunitinib—kidney cancer	3.84e-05	0.000152	CcSEcCtD
Fentanyl—Dermatitis—Sunitinib—kidney cancer	3.84e-05	0.000151	CcSEcCtD
Fentanyl—Abdominal distension—Doxorubicin—kidney cancer	3.83e-05	0.000151	CcSEcCtD
Fentanyl—Hypotension—Paclitaxel—kidney cancer	3.82e-05	0.000151	CcSEcCtD
Fentanyl—Ill-defined disorder—Capecitabine—kidney cancer	3.82e-05	0.000151	CcSEcCtD
Fentanyl—Headache—Sunitinib—kidney cancer	3.81e-05	0.000151	CcSEcCtD
Fentanyl—Dysphagia—Doxorubicin—kidney cancer	3.81e-05	0.00015	CcSEcCtD
Fentanyl—Asthma—Doxorubicin—kidney cancer	3.81e-05	0.00015	CcSEcCtD
Fentanyl—Influenza—Doxorubicin—kidney cancer	3.81e-05	0.00015	CcSEcCtD
Fentanyl—Anaemia—Capecitabine—kidney cancer	3.8e-05	0.00015	CcSEcCtD
Fentanyl—Hypersensitivity—Vincristine—kidney cancer	3.79e-05	0.00015	CcSEcCtD
Fentanyl—Nausea—Sorafenib—kidney cancer	3.76e-05	0.000148	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Paclitaxel—kidney cancer	3.73e-05	0.000147	CcSEcCtD
Fentanyl—Malaise—Capecitabine—kidney cancer	3.71e-05	0.000147	CcSEcCtD
Fentanyl—Angina pectoris—Doxorubicin—kidney cancer	3.71e-05	0.000146	CcSEcCtD
Fentanyl—Insomnia—Paclitaxel—kidney cancer	3.7e-05	0.000146	CcSEcCtD
Fentanyl—Vertigo—Capecitabine—kidney cancer	3.7e-05	0.000146	CcSEcCtD
Fentanyl—Asthenia—Vincristine—kidney cancer	3.7e-05	0.000146	CcSEcCtD
Fentanyl—Syncope—Capecitabine—kidney cancer	3.69e-05	0.000146	CcSEcCtD
Fentanyl—Leukopenia—Capecitabine—kidney cancer	3.68e-05	0.000145	CcSEcCtD
Fentanyl—Paraesthesia—Paclitaxel—kidney cancer	3.67e-05	0.000145	CcSEcCtD
Fentanyl—Vomiting—Dactinomycin—kidney cancer	3.67e-05	0.000145	CcSEcCtD
Fentanyl—Bronchitis—Doxorubicin—kidney cancer	3.66e-05	0.000145	CcSEcCtD
Fentanyl—Dyspnoea—Paclitaxel—kidney cancer	3.65e-05	0.000144	CcSEcCtD
Fentanyl—Somnolence—Paclitaxel—kidney cancer	3.64e-05	0.000144	CcSEcCtD
Fentanyl—Palpitations—Capecitabine—kidney cancer	3.64e-05	0.000144	CcSEcCtD
Fentanyl—Rash—Dactinomycin—kidney cancer	3.63e-05	0.000144	CcSEcCtD
Fentanyl—Nausea—Sunitinib—kidney cancer	3.62e-05	0.000143	CcSEcCtD
Fentanyl—Loss of consciousness—Capecitabine—kidney cancer	3.62e-05	0.000143	CcSEcCtD
Fentanyl—Pancytopenia—Doxorubicin—kidney cancer	3.61e-05	0.000143	CcSEcCtD
Fentanyl—Dyspepsia—Paclitaxel—kidney cancer	3.6e-05	0.000142	CcSEcCtD
Fentanyl—Cough—Capecitabine—kidney cancer	3.59e-05	0.000142	CcSEcCtD
Fentanyl—Dysuria—Doxorubicin—kidney cancer	3.56e-05	0.000141	CcSEcCtD
Fentanyl—Neutropenia—Doxorubicin—kidney cancer	3.56e-05	0.000141	CcSEcCtD
Fentanyl—Decreased appetite—Paclitaxel—kidney cancer	3.56e-05	0.00014	CcSEcCtD
Fentanyl—Hypertension—Capecitabine—kidney cancer	3.55e-05	0.00014	CcSEcCtD
Fentanyl—Upper respiratory tract infection—Doxorubicin—kidney cancer	3.54e-05	0.00014	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Paclitaxel—kidney cancer	3.53e-05	0.000139	CcSEcCtD
Fentanyl—Fatigue—Paclitaxel—kidney cancer	3.53e-05	0.000139	CcSEcCtD
Fentanyl—Diarrhoea—Vincristine—kidney cancer	3.52e-05	0.000139	CcSEcCtD
Fentanyl—Pollakiuria—Doxorubicin—kidney cancer	3.52e-05	0.000139	CcSEcCtD
Fentanyl—Asthenia—Gemcitabine—kidney cancer	3.51e-05	0.000138	CcSEcCtD
Fentanyl—Myalgia—Capecitabine—kidney cancer	3.5e-05	0.000138	CcSEcCtD
Fentanyl—Chest pain—Capecitabine—kidney cancer	3.5e-05	0.000138	CcSEcCtD
Fentanyl—Arthralgia—Capecitabine—kidney cancer	3.5e-05	0.000138	CcSEcCtD
Fentanyl—Pain—Paclitaxel—kidney cancer	3.5e-05	0.000138	CcSEcCtD
Fentanyl—Constipation—Paclitaxel—kidney cancer	3.5e-05	0.000138	CcSEcCtD
Fentanyl—Anxiety—Capecitabine—kidney cancer	3.49e-05	0.000138	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	3.48e-05	0.000137	CcSEcCtD
Fentanyl—Weight increased—Doxorubicin—kidney cancer	3.46e-05	0.000137	CcSEcCtD
Fentanyl—Discomfort—Capecitabine—kidney cancer	3.46e-05	0.000137	CcSEcCtD
Fentanyl—Pruritus—Gemcitabine—kidney cancer	3.46e-05	0.000137	CcSEcCtD
Fentanyl—Weight decreased—Doxorubicin—kidney cancer	3.44e-05	0.000136	CcSEcCtD
Fentanyl—Hyperglycaemia—Doxorubicin—kidney cancer	3.43e-05	0.000136	CcSEcCtD
Fentanyl—Dry mouth—Capecitabine—kidney cancer	3.42e-05	0.000135	CcSEcCtD
Fentanyl—Nausea—Dactinomycin—kidney cancer	3.42e-05	0.000135	CcSEcCtD
Fentanyl—Pneumonia—Doxorubicin—kidney cancer	3.41e-05	0.000135	CcSEcCtD
Fentanyl—Dizziness—Vincristine—kidney cancer	3.41e-05	0.000135	CcSEcCtD
Fentanyl—Drowsiness—Doxorubicin—kidney cancer	3.39e-05	0.000134	CcSEcCtD
Fentanyl—Infestation—Doxorubicin—kidney cancer	3.39e-05	0.000134	CcSEcCtD
Fentanyl—Infestation NOS—Doxorubicin—kidney cancer	3.39e-05	0.000134	CcSEcCtD
Fentanyl—Confusional state—Capecitabine—kidney cancer	3.38e-05	0.000134	CcSEcCtD
Fentanyl—Feeling abnormal—Paclitaxel—kidney cancer	3.37e-05	0.000133	CcSEcCtD
Fentanyl—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	3.36e-05	0.000133	CcSEcCtD
Fentanyl—Oedema—Capecitabine—kidney cancer	3.36e-05	0.000133	CcSEcCtD
Fentanyl—Gastrointestinal pain—Paclitaxel—kidney cancer	3.35e-05	0.000132	CcSEcCtD
Fentanyl—Diarrhoea—Gemcitabine—kidney cancer	3.34e-05	0.000132	CcSEcCtD
Fentanyl—Renal failure—Doxorubicin—kidney cancer	3.34e-05	0.000132	CcSEcCtD
Fentanyl—Infection—Capecitabine—kidney cancer	3.34e-05	0.000132	CcSEcCtD
Fentanyl—Neuropathy peripheral—Doxorubicin—kidney cancer	3.33e-05	0.000131	CcSEcCtD
Fentanyl—Stomatitis—Doxorubicin—kidney cancer	3.31e-05	0.000131	CcSEcCtD
Fentanyl—Jaundice—Doxorubicin—kidney cancer	3.31e-05	0.000131	CcSEcCtD
Fentanyl—Shock—Capecitabine—kidney cancer	3.3e-05	0.00013	CcSEcCtD
Fentanyl—Urinary tract infection—Doxorubicin—kidney cancer	3.3e-05	0.00013	CcSEcCtD
Fentanyl—Conjunctivitis—Doxorubicin—kidney cancer	3.3e-05	0.00013	CcSEcCtD
Fentanyl—Nervous system disorder—Capecitabine—kidney cancer	3.29e-05	0.00013	CcSEcCtD
Fentanyl—Thrombocytopenia—Capecitabine—kidney cancer	3.29e-05	0.00013	CcSEcCtD
Fentanyl—Tachycardia—Capecitabine—kidney cancer	3.28e-05	0.000129	CcSEcCtD
Fentanyl—Vomiting—Vincristine—kidney cancer	3.27e-05	0.000129	CcSEcCtD
Fentanyl—Skin disorder—Capecitabine—kidney cancer	3.26e-05	0.000129	CcSEcCtD
Fentanyl—Sweating—Doxorubicin—kidney cancer	3.25e-05	0.000128	CcSEcCtD
Fentanyl—Urticaria—Paclitaxel—kidney cancer	3.25e-05	0.000128	CcSEcCtD
Fentanyl—Rash—Vincristine—kidney cancer	3.25e-05	0.000128	CcSEcCtD
Fentanyl—Hyperhidrosis—Capecitabine—kidney cancer	3.25e-05	0.000128	CcSEcCtD
Fentanyl—Dermatitis—Vincristine—kidney cancer	3.24e-05	0.000128	CcSEcCtD
Fentanyl—Haematuria—Doxorubicin—kidney cancer	3.24e-05	0.000128	CcSEcCtD
Fentanyl—Abdominal pain—Paclitaxel—kidney cancer	3.23e-05	0.000128	CcSEcCtD
Fentanyl—Body temperature increased—Paclitaxel—kidney cancer	3.23e-05	0.000128	CcSEcCtD
Fentanyl—Headache—Vincristine—kidney cancer	3.23e-05	0.000127	CcSEcCtD
Fentanyl—Hepatobiliary disease—Doxorubicin—kidney cancer	3.21e-05	0.000127	CcSEcCtD
Fentanyl—Epistaxis—Doxorubicin—kidney cancer	3.2e-05	0.000126	CcSEcCtD
Fentanyl—Anorexia—Capecitabine—kidney cancer	3.2e-05	0.000126	CcSEcCtD
Fentanyl—Sinusitis—Doxorubicin—kidney cancer	3.18e-05	0.000126	CcSEcCtD
Fentanyl—Hypotension—Capecitabine—kidney cancer	3.14e-05	0.000124	CcSEcCtD
Fentanyl—Vomiting—Gemcitabine—kidney cancer	3.11e-05	0.000123	CcSEcCtD
Fentanyl—Bradycardia—Doxorubicin—kidney cancer	3.1e-05	0.000122	CcSEcCtD
Fentanyl—Rash—Gemcitabine—kidney cancer	3.08e-05	0.000122	CcSEcCtD
Fentanyl—Dermatitis—Gemcitabine—kidney cancer	3.08e-05	0.000122	CcSEcCtD
Fentanyl—Haemoglobin—Doxorubicin—kidney cancer	3.06e-05	0.000121	CcSEcCtD
Fentanyl—Headache—Gemcitabine—kidney cancer	3.06e-05	0.000121	CcSEcCtD
Fentanyl—Nausea—Vincristine—kidney cancer	3.06e-05	0.000121	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Capecitabine—kidney cancer	3.06e-05	0.000121	CcSEcCtD
Fentanyl—Rhinitis—Doxorubicin—kidney cancer	3.05e-05	0.000121	CcSEcCtD
Fentanyl—Haemorrhage—Doxorubicin—kidney cancer	3.05e-05	0.00012	CcSEcCtD
Fentanyl—Insomnia—Capecitabine—kidney cancer	3.04e-05	0.00012	CcSEcCtD
Fentanyl—Hypoaesthesia—Doxorubicin—kidney cancer	3.03e-05	0.00012	CcSEcCtD
Fentanyl—Pharyngitis—Doxorubicin—kidney cancer	3.02e-05	0.000119	CcSEcCtD
Fentanyl—Paraesthesia—Capecitabine—kidney cancer	3.01e-05	0.000119	CcSEcCtD
Fentanyl—Hypersensitivity—Paclitaxel—kidney cancer	3.01e-05	0.000119	CcSEcCtD
Fentanyl—Urinary tract disorder—Doxorubicin—kidney cancer	3.01e-05	0.000119	CcSEcCtD
Fentanyl—Oedema peripheral—Doxorubicin—kidney cancer	3e-05	0.000119	CcSEcCtD
Fentanyl—Connective tissue disorder—Doxorubicin—kidney cancer	2.99e-05	0.000118	CcSEcCtD
Fentanyl—Dyspnoea—Capecitabine—kidney cancer	2.99e-05	0.000118	CcSEcCtD
Fentanyl—Urethral disorder—Doxorubicin—kidney cancer	2.99e-05	0.000118	CcSEcCtD
Fentanyl—Dyspepsia—Capecitabine—kidney cancer	2.96e-05	0.000117	CcSEcCtD
Fentanyl—Visual impairment—Doxorubicin—kidney cancer	2.94e-05	0.000116	CcSEcCtD
Fentanyl—Asthenia—Paclitaxel—kidney cancer	2.94e-05	0.000116	CcSEcCtD
Fentanyl—Decreased appetite—Capecitabine—kidney cancer	2.92e-05	0.000115	CcSEcCtD
Fentanyl—Nausea—Gemcitabine—kidney cancer	2.9e-05	0.000115	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Capecitabine—kidney cancer	2.9e-05	0.000114	CcSEcCtD
Fentanyl—Fatigue—Capecitabine—kidney cancer	2.89e-05	0.000114	CcSEcCtD
Fentanyl—Pruritus—Paclitaxel—kidney cancer	2.89e-05	0.000114	CcSEcCtD
Fentanyl—Erythema multiforme—Doxorubicin—kidney cancer	2.88e-05	0.000114	CcSEcCtD
Fentanyl—Pain—Capecitabine—kidney cancer	2.87e-05	0.000113	CcSEcCtD
Fentanyl—Constipation—Capecitabine—kidney cancer	2.87e-05	0.000113	CcSEcCtD
Fentanyl—Eye disorder—Doxorubicin—kidney cancer	2.85e-05	0.000112	CcSEcCtD
Fentanyl—Tinnitus—Doxorubicin—kidney cancer	2.84e-05	0.000112	CcSEcCtD
Fentanyl—Cardiac disorder—Doxorubicin—kidney cancer	2.83e-05	0.000112	CcSEcCtD
Fentanyl—Flushing—Doxorubicin—kidney cancer	2.83e-05	0.000112	CcSEcCtD
Fentanyl—Diarrhoea—Paclitaxel—kidney cancer	2.8e-05	0.000111	CcSEcCtD
Fentanyl—Feeling abnormal—Capecitabine—kidney cancer	2.77e-05	0.000109	CcSEcCtD
Fentanyl—Angiopathy—Doxorubicin—kidney cancer	2.76e-05	0.000109	CcSEcCtD
Fentanyl—Immune system disorder—Doxorubicin—kidney cancer	2.75e-05	0.000109	CcSEcCtD
Fentanyl—Gastrointestinal pain—Capecitabine—kidney cancer	2.75e-05	0.000108	CcSEcCtD
Fentanyl—Mediastinal disorder—Doxorubicin—kidney cancer	2.75e-05	0.000108	CcSEcCtD
Fentanyl—Chills—Doxorubicin—kidney cancer	2.73e-05	0.000108	CcSEcCtD
Fentanyl—Arrhythmia—Doxorubicin—kidney cancer	2.72e-05	0.000107	CcSEcCtD
Fentanyl—Dizziness—Paclitaxel—kidney cancer	2.71e-05	0.000107	CcSEcCtD
Fentanyl—Alopecia—Doxorubicin—kidney cancer	2.69e-05	0.000106	CcSEcCtD
Fentanyl—Mental disorder—Doxorubicin—kidney cancer	2.67e-05	0.000105	CcSEcCtD
Fentanyl—Urticaria—Capecitabine—kidney cancer	2.67e-05	0.000105	CcSEcCtD
Fentanyl—Abdominal pain—Capecitabine—kidney cancer	2.65e-05	0.000105	CcSEcCtD
Fentanyl—Body temperature increased—Capecitabine—kidney cancer	2.65e-05	0.000105	CcSEcCtD
Fentanyl—Malnutrition—Doxorubicin—kidney cancer	2.65e-05	0.000105	CcSEcCtD
Fentanyl—Erythema—Doxorubicin—kidney cancer	2.65e-05	0.000105	CcSEcCtD
Fentanyl—Flatulence—Doxorubicin—kidney cancer	2.61e-05	0.000103	CcSEcCtD
Fentanyl—Tension—Doxorubicin—kidney cancer	2.6e-05	0.000103	CcSEcCtD
Fentanyl—Vomiting—Paclitaxel—kidney cancer	2.6e-05	0.000103	CcSEcCtD
Fentanyl—Dysgeusia—Doxorubicin—kidney cancer	2.6e-05	0.000103	CcSEcCtD
Fentanyl—Rash—Paclitaxel—kidney cancer	2.58e-05	0.000102	CcSEcCtD
Fentanyl—Dermatitis—Paclitaxel—kidney cancer	2.58e-05	0.000102	CcSEcCtD
Fentanyl—Nervousness—Doxorubicin—kidney cancer	2.58e-05	0.000102	CcSEcCtD
Fentanyl—Back pain—Doxorubicin—kidney cancer	2.56e-05	0.000101	CcSEcCtD
Fentanyl—Headache—Paclitaxel—kidney cancer	2.56e-05	0.000101	CcSEcCtD
Fentanyl—Muscle spasms—Doxorubicin—kidney cancer	2.55e-05	0.000101	CcSEcCtD
Fentanyl—Vision blurred—Doxorubicin—kidney cancer	2.5e-05	9.87e-05	CcSEcCtD
Fentanyl—Hypersensitivity—Capecitabine—kidney cancer	2.47e-05	9.77e-05	CcSEcCtD
Fentanyl—Ill-defined disorder—Doxorubicin—kidney cancer	2.46e-05	9.72e-05	CcSEcCtD
Fentanyl—Anaemia—Doxorubicin—kidney cancer	2.45e-05	9.68e-05	CcSEcCtD
Fentanyl—Agitation—Doxorubicin—kidney cancer	2.44e-05	9.62e-05	CcSEcCtD
Fentanyl—Nausea—Paclitaxel—kidney cancer	2.43e-05	9.6e-05	CcSEcCtD
Fentanyl—Asthenia—Capecitabine—kidney cancer	2.41e-05	9.51e-05	CcSEcCtD
Fentanyl—Malaise—Doxorubicin—kidney cancer	2.39e-05	9.44e-05	CcSEcCtD
Fentanyl—Vertigo—Doxorubicin—kidney cancer	2.38e-05	9.41e-05	CcSEcCtD
Fentanyl—Syncope—Doxorubicin—kidney cancer	2.38e-05	9.39e-05	CcSEcCtD
Fentanyl—Pruritus—Capecitabine—kidney cancer	2.38e-05	9.38e-05	CcSEcCtD
Fentanyl—Leukopenia—Doxorubicin—kidney cancer	2.37e-05	9.37e-05	CcSEcCtD
Fentanyl—Palpitations—Doxorubicin—kidney cancer	2.34e-05	9.25e-05	CcSEcCtD
Fentanyl—Loss of consciousness—Doxorubicin—kidney cancer	2.33e-05	9.2e-05	CcSEcCtD
Fentanyl—Cough—Doxorubicin—kidney cancer	2.31e-05	9.14e-05	CcSEcCtD
Fentanyl—Convulsion—Doxorubicin—kidney cancer	2.3e-05	9.07e-05	CcSEcCtD
Fentanyl—Diarrhoea—Capecitabine—kidney cancer	2.3e-05	9.07e-05	CcSEcCtD
Fentanyl—Hypertension—Doxorubicin—kidney cancer	2.29e-05	9.04e-05	CcSEcCtD
Fentanyl—Chest pain—Doxorubicin—kidney cancer	2.26e-05	8.92e-05	CcSEcCtD
Fentanyl—Myalgia—Doxorubicin—kidney cancer	2.26e-05	8.92e-05	CcSEcCtD
Fentanyl—Arthralgia—Doxorubicin—kidney cancer	2.26e-05	8.92e-05	CcSEcCtD
Fentanyl—Anxiety—Doxorubicin—kidney cancer	2.25e-05	8.88e-05	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	2.24e-05	8.85e-05	CcSEcCtD
Fentanyl—Discomfort—Doxorubicin—kidney cancer	2.23e-05	8.81e-05	CcSEcCtD
Fentanyl—Dizziness—Capecitabine—kidney cancer	2.22e-05	8.77e-05	CcSEcCtD
Fentanyl—Dry mouth—Doxorubicin—kidney cancer	2.21e-05	8.72e-05	CcSEcCtD
Fentanyl—Confusional state—Doxorubicin—kidney cancer	2.18e-05	8.62e-05	CcSEcCtD
Fentanyl—Oedema—Doxorubicin—kidney cancer	2.16e-05	8.55e-05	CcSEcCtD
Fentanyl—Anaphylactic shock—Doxorubicin—kidney cancer	2.16e-05	8.55e-05	CcSEcCtD
Fentanyl—Infection—Doxorubicin—kidney cancer	2.15e-05	8.49e-05	CcSEcCtD
Fentanyl—Vomiting—Capecitabine—kidney cancer	2.13e-05	8.43e-05	CcSEcCtD
Fentanyl—Shock—Doxorubicin—kidney cancer	2.13e-05	8.41e-05	CcSEcCtD
Fentanyl—Nervous system disorder—Doxorubicin—kidney cancer	2.12e-05	8.38e-05	CcSEcCtD
Fentanyl—Thrombocytopenia—Doxorubicin—kidney cancer	2.12e-05	8.37e-05	CcSEcCtD
Fentanyl—Rash—Capecitabine—kidney cancer	2.12e-05	8.36e-05	CcSEcCtD
Fentanyl—Dermatitis—Capecitabine—kidney cancer	2.11e-05	8.35e-05	CcSEcCtD
Fentanyl—Tachycardia—Doxorubicin—kidney cancer	2.11e-05	8.34e-05	CcSEcCtD
Fentanyl—Headache—Capecitabine—kidney cancer	2.1e-05	8.31e-05	CcSEcCtD
Fentanyl—Skin disorder—Doxorubicin—kidney cancer	2.1e-05	8.3e-05	CcSEcCtD
Fentanyl—Hyperhidrosis—Doxorubicin—kidney cancer	2.09e-05	8.26e-05	CcSEcCtD
Fentanyl—Anorexia—Doxorubicin—kidney cancer	2.06e-05	8.15e-05	CcSEcCtD
Fentanyl—Hypotension—Doxorubicin—kidney cancer	2.02e-05	7.99e-05	CcSEcCtD
Fentanyl—Nausea—Capecitabine—kidney cancer	1.99e-05	7.88e-05	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Doxorubicin—kidney cancer	1.97e-05	7.79e-05	CcSEcCtD
Fentanyl—Insomnia—Doxorubicin—kidney cancer	1.96e-05	7.73e-05	CcSEcCtD
Fentanyl—Paraesthesia—Doxorubicin—kidney cancer	1.94e-05	7.67e-05	CcSEcCtD
Fentanyl—Dyspnoea—Doxorubicin—kidney cancer	1.93e-05	7.62e-05	CcSEcCtD
Fentanyl—Somnolence—Doxorubicin—kidney cancer	1.92e-05	7.6e-05	CcSEcCtD
Fentanyl—Dyspepsia—Doxorubicin—kidney cancer	1.9e-05	7.52e-05	CcSEcCtD
Fentanyl—Decreased appetite—Doxorubicin—kidney cancer	1.88e-05	7.43e-05	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Doxorubicin—kidney cancer	1.87e-05	7.38e-05	CcSEcCtD
Fentanyl—Fatigue—Doxorubicin—kidney cancer	1.87e-05	7.37e-05	CcSEcCtD
Fentanyl—Constipation—Doxorubicin—kidney cancer	1.85e-05	7.31e-05	CcSEcCtD
Fentanyl—Pain—Doxorubicin—kidney cancer	1.85e-05	7.31e-05	CcSEcCtD
Fentanyl—Feeling abnormal—Doxorubicin—kidney cancer	1.78e-05	7.04e-05	CcSEcCtD
Fentanyl—Gastrointestinal pain—Doxorubicin—kidney cancer	1.77e-05	6.99e-05	CcSEcCtD
Fentanyl—Urticaria—Doxorubicin—kidney cancer	1.72e-05	6.79e-05	CcSEcCtD
Fentanyl—Body temperature increased—Doxorubicin—kidney cancer	1.71e-05	6.76e-05	CcSEcCtD
Fentanyl—Abdominal pain—Doxorubicin—kidney cancer	1.71e-05	6.76e-05	CcSEcCtD
Fentanyl—Hypersensitivity—Doxorubicin—kidney cancer	1.59e-05	6.3e-05	CcSEcCtD
Fentanyl—Asthenia—Doxorubicin—kidney cancer	1.55e-05	6.13e-05	CcSEcCtD
Fentanyl—Pruritus—Doxorubicin—kidney cancer	1.53e-05	6.05e-05	CcSEcCtD
Fentanyl—Diarrhoea—Doxorubicin—kidney cancer	1.48e-05	5.85e-05	CcSEcCtD
Fentanyl—Dizziness—Doxorubicin—kidney cancer	1.43e-05	5.65e-05	CcSEcCtD
Fentanyl—Vomiting—Doxorubicin—kidney cancer	1.38e-05	5.43e-05	CcSEcCtD
Fentanyl—Rash—Doxorubicin—kidney cancer	1.36e-05	5.39e-05	CcSEcCtD
Fentanyl—Dermatitis—Doxorubicin—kidney cancer	1.36e-05	5.38e-05	CcSEcCtD
Fentanyl—Headache—Doxorubicin—kidney cancer	1.36e-05	5.35e-05	CcSEcCtD
Fentanyl—Nausea—Doxorubicin—kidney cancer	1.29e-05	5.08e-05	CcSEcCtD
Fentanyl—OPRM1—Signaling Pathways—GRB7—kidney cancer	2.42e-06	0.000857	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CTNNA1—kidney cancer	2.41e-06	0.000855	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HSPB1—kidney cancer	2.4e-06	0.00085	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—EIF4EBP1—kidney cancer	2.4e-06	0.00085	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—POMC—kidney cancer	2.32e-06	0.000823	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ITPR2—kidney cancer	2.31e-06	0.00082	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—APRT—kidney cancer	2.3e-06	0.000816	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—FH—kidney cancer	2.3e-06	0.000816	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	2.3e-06	0.000814	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PAK1—kidney cancer	2.28e-06	0.000809	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—JUNB—kidney cancer	2.28e-06	0.000809	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	2.27e-06	0.000805	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ITPR2—kidney cancer	2.25e-06	0.000797	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PSMD7—kidney cancer	2.23e-06	0.00079	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ANXA1—kidney cancer	2.23e-06	0.00079	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TSC1—kidney cancer	2.23e-06	0.00079	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	2.22e-06	0.000787	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ACY1—kidney cancer	2.2e-06	0.00078	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GPC3—kidney cancer	2.16e-06	0.000767	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—FLT1—kidney cancer	2.16e-06	0.000765	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CA9—kidney cancer	2.11e-06	0.00075	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.11e-06	0.000749	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GSTT1—kidney cancer	2.11e-06	0.000748	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ACHE—kidney cancer	2.11e-06	0.000748	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—POMC—kidney cancer	2.11e-06	0.000747	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CA2—kidney cancer	2.11e-06	0.000746	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	2.1e-06	0.000746	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ALAD—kidney cancer	2.05e-06	0.000727	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.04e-06	0.000724	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CTNNA1—kidney cancer	2.04e-06	0.000723	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—POMC—kidney cancer	2.04e-06	0.000722	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—EIF4EBP1—kidney cancer	2.03e-06	0.000718	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HSPB1—kidney cancer	2.03e-06	0.000718	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	2.01e-06	0.000711	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ST3GAL2—kidney cancer	2e-06	0.00071	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	2e-06	0.00071	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—JUNB—kidney cancer	2e-06	0.00071	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PAK1—kidney cancer	2e-06	0.00071	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—SCARB1—kidney cancer	2e-06	0.000708	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.99e-06	0.000705	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PTGS1—kidney cancer	1.98e-06	0.000701	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.96e-06	0.000694	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PSMD7—kidney cancer	1.94e-06	0.000687	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.94e-06	0.000687	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PSMD7—kidney cancer	1.88e-06	0.000668	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TSC1—kidney cancer	1.88e-06	0.000668	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ANXA1—kidney cancer	1.88e-06	0.000668	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PGK1—kidney cancer	1.88e-06	0.000665	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SLC5A3—kidney cancer	1.88e-06	0.000665	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PDHB—kidney cancer	1.87e-06	0.000664	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IGF2—kidney cancer	1.87e-06	0.000662	CbGpPWpGaD
Fentanyl—CYP3A4—Biological oxidations—POMC—kidney cancer	1.87e-06	0.000661	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CDKN2B—kidney cancer	1.86e-06	0.000659	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—POMC—kidney cancer	1.85e-06	0.000655	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—LDHB—kidney cancer	1.84e-06	0.000652	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—BCHE—kidney cancer	1.84e-06	0.000651	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—FLT1—kidney cancer	1.82e-06	0.000647	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—SLC5A5—kidney cancer	1.81e-06	0.000643	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IGF1R—kidney cancer	1.8e-06	0.00064	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CRABP1—kidney cancer	1.8e-06	0.000637	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CCBL1—kidney cancer	1.76e-06	0.000624	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—SLC2A1—kidney cancer	1.75e-06	0.000621	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.75e-06	0.00062	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—RAF1—kidney cancer	1.74e-06	0.000616	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—POMC—kidney cancer	1.72e-06	0.00061	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—IL2—kidney cancer	1.72e-06	0.000609	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PAK1—kidney cancer	1.69e-06	0.0006	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—JUNB—kidney cancer	1.69e-06	0.0006	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ITPR2—kidney cancer	1.67e-06	0.000593	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.65e-06	0.000587	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IGF2—kidney cancer	1.64e-06	0.00058	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CDKN2B—kidney cancer	1.63e-06	0.000578	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.61e-06	0.000571	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CA9—kidney cancer	1.6e-06	0.000566	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IGF1R—kidney cancer	1.58e-06	0.000561	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.57e-06	0.000558	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—POMC—kidney cancer	1.56e-06	0.000554	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—IL2—kidney cancer	1.56e-06	0.000553	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.53e-06	0.000541	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PPAT—kidney cancer	1.53e-06	0.000541	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—RAF1—kidney cancer	1.52e-06	0.00054	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ACHE—kidney cancer	1.52e-06	0.00054	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GSTT1—kidney cancer	1.52e-06	0.00054	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—IL2—kidney cancer	1.5e-06	0.000534	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.49e-06	0.000527	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—HIF1A—kidney cancer	1.48e-06	0.000527	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TSC2—kidney cancer	1.48e-06	0.000525	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GSTP1—kidney cancer	1.46e-06	0.000518	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—SCARB1—kidney cancer	1.44e-06	0.000512	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PTGS1—kidney cancer	1.43e-06	0.000506	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—KDR—kidney cancer	1.42e-06	0.000504	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—FH—kidney cancer	1.42e-06	0.000503	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—APRT—kidney cancer	1.42e-06	0.000503	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PSMD7—kidney cancer	1.4e-06	0.000497	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ABCB1—kidney cancer	1.38e-06	0.000491	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IGF2—kidney cancer	1.38e-06	0.00049	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CDKN2B—kidney cancer	1.38e-06	0.000488	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IL2—kidney cancer	1.37e-06	0.000485	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.37e-06	0.000484	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CRABP1—kidney cancer	1.36e-06	0.000481	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GSTM1—kidney cancer	1.34e-06	0.000476	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IGF1R—kidney cancer	1.34e-06	0.000474	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GPC3—kidney cancer	1.33e-06	0.000473	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—BCHE—kidney cancer	1.33e-06	0.000471	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.32e-06	0.000469	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—SLC5A5—kidney cancer	1.31e-06	0.000465	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—KIT—kidney cancer	1.31e-06	0.000464	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—APC—kidney cancer	1.31e-06	0.000464	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HIF1A—kidney cancer	1.3e-06	0.000462	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TSC2—kidney cancer	1.3e-06	0.000461	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CA2—kidney cancer	1.3e-06	0.00046	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—RAF1—kidney cancer	1.29e-06	0.000457	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CYP1A1—kidney cancer	1.27e-06	0.000451	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—IL2—kidney cancer	1.27e-06	0.000451	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—SLC2A1—kidney cancer	1.27e-06	0.000449	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ALAD—kidney cancer	1.26e-06	0.000448	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ITPR2—kidney cancer	1.26e-06	0.000447	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—MAPK3—kidney cancer	1.25e-06	0.000444	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—POMC—kidney cancer	1.25e-06	0.000442	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—KDR—kidney cancer	1.25e-06	0.000442	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.23e-06	0.000437	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—BRAF—kidney cancer	1.23e-06	0.000436	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.21e-06	0.000428	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—MAPK1—kidney cancer	1.19e-06	0.000423	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PGK1—kidney cancer	1.16e-06	0.00041	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.16e-06	0.00041	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL2—kidney cancer	1.15e-06	0.00041	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GSTT1—kidney cancer	1.15e-06	0.000408	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ACHE—kidney cancer	1.15e-06	0.000408	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—APC—kidney cancer	1.15e-06	0.000407	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—KIT—kidney cancer	1.15e-06	0.000407	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—PIK3CA—kidney cancer	1.14e-06	0.000404	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—LDHB—kidney cancer	1.13e-06	0.000402	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—KRAS—kidney cancer	1.13e-06	0.000399	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HIF1A—kidney cancer	1.1e-06	0.00039	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—MAPK3—kidney cancer	1.1e-06	0.00039	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TSC2—kidney cancer	1.1e-06	0.000389	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—POMC—kidney cancer	1.09e-06	0.000387	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SCARB1—kidney cancer	1.09e-06	0.000386	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—BRAF—kidney cancer	1.08e-06	0.000382	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PTGS1—kidney cancer	1.08e-06	0.000382	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PSMD7—kidney cancer	1.06e-06	0.000375	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GSTP1—kidney cancer	1.06e-06	0.000375	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—KDR—kidney cancer	1.05e-06	0.000373	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—MAPK1—kidney cancer	1.05e-06	0.000371	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—PIK3CA—kidney cancer	1.03e-06	0.000367	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—RAF1—kidney cancer	1.03e-06	0.000364	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—RELA—kidney cancer	1.02e-06	0.000362	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ERBB2—kidney cancer	1.02e-06	0.00036	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MTOR—kidney cancer	1e-06	0.000355	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—BCHE—kidney cancer	1e-06	0.000355	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ABCB1—kidney cancer	1e-06	0.000355	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—PIK3CA—kidney cancer	9.99e-07	0.000354	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SLC5A5—kidney cancer	9.9e-07	0.000351	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—KRAS—kidney cancer	9.87e-07	0.00035	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CA9—kidney cancer	9.83e-07	0.000349	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GSTM1—kidney cancer	9.71e-07	0.000344	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—APC—kidney cancer	9.69e-07	0.000344	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—KIT—kidney cancer	9.69e-07	0.000344	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SLC2A1—kidney cancer	9.56e-07	0.000339	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—POMC—kidney cancer	9.49e-07	0.000337	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CDKN1B—kidney cancer	9.41e-07	0.000334	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—MAPK3—kidney cancer	9.28e-07	0.000329	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—POMC—kidney cancer	9.23e-07	0.000327	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL2—kidney cancer	9.21e-07	0.000326	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CYP1A1—kidney cancer	9.2e-07	0.000326	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	9.11e-07	0.000323	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—BRAF—kidney cancer	9.11e-07	0.000323	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—PIK3CA—kidney cancer	9.07e-07	0.000322	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—RAF1—kidney cancer	9e-07	0.000319	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CCND1—kidney cancer	8.97e-07	0.000318	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—RELA—kidney cancer	8.96e-07	0.000318	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—JUN—kidney cancer	8.96e-07	0.000318	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ERBB2—kidney cancer	8.91e-07	0.000316	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CTNNB1—kidney cancer	8.89e-07	0.000315	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—MAPK1—kidney cancer	8.83e-07	0.000313	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MTOR—kidney cancer	8.79e-07	0.000312	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PTEN—kidney cancer	8.66e-07	0.000307	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—PIK3CA—kidney cancer	8.44e-07	0.000299	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CRABP1—kidney cancer	8.36e-07	0.000296	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—KRAS—kidney cancer	8.34e-07	0.000296	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CDKN1B—kidney cancer	8.25e-07	0.000293	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL2—kidney cancer	8.07e-07	0.000286	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GSTP1—kidney cancer	7.97e-07	0.000283	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CCND1—kidney cancer	7.87e-07	0.000279	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—JUN—kidney cancer	7.85e-07	0.000278	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—VEGFA—kidney cancer	7.82e-07	0.000277	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CTNNB1—kidney cancer	7.79e-07	0.000276	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ITPR2—kidney cancer	7.77e-07	0.000276	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PIK3CA—kidney cancer	7.67e-07	0.000272	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—RAF1—kidney cancer	7.61e-07	0.00027	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PTEN—kidney cancer	7.6e-07	0.000269	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—RELA—kidney cancer	7.58e-07	0.000269	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PTGS2—kidney cancer	7.57e-07	0.000268	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ERBB2—kidney cancer	7.53e-07	0.000267	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MTOR—kidney cancer	7.43e-07	0.000263	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MAPK3—kidney cancer	7.4e-07	0.000262	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GSTM1—kidney cancer	7.32e-07	0.00026	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MYC—kidney cancer	7.2e-07	0.000255	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ACHE—kidney cancer	7.09e-07	0.000251	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTT1—kidney cancer	7.09e-07	0.000251	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MAPK1—kidney cancer	7.04e-07	0.00025	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CDKN1B—kidney cancer	6.97e-07	0.000247	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP1A1—kidney cancer	6.94e-07	0.000246	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—POMC—kidney cancer	6.86e-07	0.000243	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—VEGFA—kidney cancer	6.86e-07	0.000243	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL2—kidney cancer	6.82e-07	0.000242	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SCARB1—kidney cancer	6.71e-07	0.000238	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—KRAS—kidney cancer	6.65e-07	0.000236	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CCND1—kidney cancer	6.65e-07	0.000236	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PTGS1—kidney cancer	6.64e-07	0.000235	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—JUN—kidney cancer	6.64e-07	0.000235	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PTEN—kidney cancer	6.6e-07	0.000234	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CTNNB1—kidney cancer	6.59e-07	0.000234	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PSMD7—kidney cancer	6.51e-07	0.000231	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MAPK3—kidney cancer	6.49e-07	0.00023	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PTEN—kidney cancer	6.42e-07	0.000228	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MYC—kidney cancer	6.31e-07	0.000224	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MAPK1—kidney cancer	6.17e-07	0.000219	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—BCHE—kidney cancer	6.17e-07	0.000219	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3CA—kidney cancer	6.11e-07	0.000217	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SLC5A5—kidney cancer	6.1e-07	0.000216	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TP53—kidney cancer	5.91e-07	0.00021	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SLC2A1—kidney cancer	5.89e-07	0.000209	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—KRAS—kidney cancer	5.83e-07	0.000207	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—VEGFA—kidney cancer	5.8e-07	0.000206	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MAPK3—kidney cancer	5.48e-07	0.000194	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PTGS2—kidney cancer	5.47e-07	0.000194	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CA—kidney cancer	5.36e-07	0.00019	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MYC—kidney cancer	5.33e-07	0.000189	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MAPK1—kidney cancer	5.22e-07	0.000185	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TP53—kidney cancer	5.18e-07	0.000184	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—POMC—kidney cancer	5.18e-07	0.000184	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—KRAS—kidney cancer	4.93e-07	0.000175	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTP1—kidney cancer	4.91e-07	0.000174	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PTEN—kidney cancer	4.77e-07	0.000169	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CA—kidney cancer	4.66e-07	0.000165	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ABCB1—kidney cancer	4.65e-07	0.000165	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CA—kidney cancer	4.53e-07	0.000161	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTM1—kidney cancer	4.51e-07	0.00016	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TP53—kidney cancer	4.38e-07	0.000155	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP1A1—kidney cancer	4.28e-07	0.000152	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PTGS2—kidney cancer	4.13e-07	0.000146	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PTEN—kidney cancer	3.6e-07	0.000128	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CA—kidney cancer	3.37e-07	0.000119	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—POMC—kidney cancer	3.19e-07	0.000113	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PTGS2—kidney cancer	2.54e-07	9.02e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CA—kidney cancer	2.54e-07	9.01e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PTEN—kidney cancer	2.22e-07	7.87e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.57e-07	5.55e-05	CbGpPWpGaD
